Skip to main content
Caplight Logo









Astralytix

Astralytix

Private
LeuvenHealthcare & Life Scienceshttps://astralytix.com

Last Round

Accelerator

May 19, 2026

Total Funding Raised

$20,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Astralytix is a biotechnology company that develops FibriLysin technology to create next-generation antimicrobials for treating resistant staphylococcal infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologyantimicrobial therapyantibacterial enzymesFibriLysinendolysinsantibiotic resistancebiofilm disruptionsuperbug treatmentdrug discoveryprotein engineeringsynthetic biologystaphylococcal infectionspharma licensingpreclinical developmentbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Astralytix Comparables

Compare Astralytix with similar companies based on industry and business-model similarity.

Astralytix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Obulytix
83%
Resistia
81%
PrecisioBiotix Therapeutics
79%

Astralytix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 19, 2026
GrantMar 4, 2026

Astralytix Investors

Notable investors and investment history

Astralytix investors
InvestorRounds
INCATEAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    $10K raised from INCATE accelerator.

  • Mar 4, 2026

    Secured $10K in grant funding.

Astralytix Filings

Explore SEC and related filing metadata, where available.

Astralytix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Astralytix's valuation, stock price, and market status.

Is Astralytix a public or private company?

Astralytix is a private company.

What is the current stock price of Astralytix?

Astralytix is a private company with no public stock price. Caplight tracks Astralytix's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Astralytix worth (valuation)?

Valuation information for Astralytix is not publicly available.

Can I buy Astralytix stock?

Astralytix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Astralytix's last funding round?

Astralytix's most recent funding round was Accelerator on May 19, 2026.

Who are the main investors in Astralytix?

Key investors in Astralytix include INCATE.

Will Astralytix IPO soon?

No public IPO plans have been announced for Astralytix.

How can I track Astralytix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Astralytix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeuven
Year FoundedN/A
Last FundingMay 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?